Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer

Clinical and Experimental Metastasis

Volumn 21, Issue 1, 2004, Pages 31-37

  Davies, Gaynor ^a   Cunnick, Giles H ^a   Mansel, Robert E ^a   Mason, Malcolm D ^b   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b VELINDRE CANCER CENTRE   (United Kingdom)

Author keywords

Angiogenesis; Breast cancer; Q RT PCR; TEMs

Indexed keywords

BETA ACTIN; ENDOSIALIN; TUMOR ENDOTHELIAL MARKER; TUMOR ENDOTHELIAL MARKER 2; TUMOR ENDOTHELIAL MARKER 4; TUMOR ENDOTHELIAL MARKER 5; TUMOR ENDOTHELIAL MARKER 6; TUMOR ENDOTHELIAL MARKER 7; TUMOR ENDOTHELIAL MARKER 7R; TUMOR ENDOTHELIAL MARKER 8; TUMOR MARKER; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER PATIENT; CANCER RECURRENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; DISEASE MARKER; ENDOTHELIUM CELL; FOLLOW UP; FROZEN SECTION; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; STATISTICAL SIGNIFICANCE;

BASE SEQUENCE; BREAST NEOPLASMS; DNA PRIMERS; ENDOTHELIUM, VASCULAR; HUMANS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 1642333026     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CLIN.0000017168.83616.d0     Document Type: Article

References (31)

1. Fisher B, Bauer M, Wickerham DL et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 1983; 52: 1551-7.
2. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989; 63: 181-7.
3. Forbes JF. The incidence of breast cancer: The global burden, public health considerations. Semin Oncol 1997; 24: 20-35.
4. Cunnick GH, Jiang WG, Gomez KF et al. Lymphangiogenesis and breast cancer metastasis. Histol Histopathol 2002; 17: 863-70.
5. Jiang WG, Martin TA, Mansel RE. Molecular detection of microy-metastasis in breast cancer. Crit Rev Oncol Hematol 2002; 43: 13-31.
6. Weidner N, Semple JP, Welch WR et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
7. Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol Rev 2002; 82: 673-700.
8. Tanaka F, Otake Y, Yanagihara K et al. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Clin Cancer Res 2001; 7: 3410-5.
9. Rice A, Quinn CM. Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast. J Clin Pathol 2002; 55: 569-74.
10. Papetti M, Herman IM. Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 2002; 282: C947-C70.
11. 'Reilly MS, Holmgren L, Shing Y et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315-28.
12. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 1995; 333: 1757-63.
13. Maglione D, Guerriero V, Viglietto G et al. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 1991; 88: 9267-71.
14. O'Reilly MS, Boehm T, Shing Y et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-85.
15. Senger DR, Galli SJ, Dvorak AM et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983-5.
16. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Comm 1989; 161: 851-8.
17. Gospodarowicz D, Abraham JA, Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 1989; 86: 7311-5.
18. Solovey AN, Gui L, Chang L et al. Identification and functional assessment of endothelial P1H12. J Lab Clin Med 2001; 138: 322-31.
19. St Croix B, Rago C, Velculescu V et al. Genes expressed in human tumor endothelium. Science 2000; 289: 1197-202.
20. Teo NB, Shoker BS, Jarvis C et al. Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast. Br J Cancer 2002; 86: 905-11.
21. Carson-Walter EB, Watkins DN, Nanda A et al. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 2001; 61: 6649-55.
22. Jiang WG, Douglas-Jones A, Mansel RE. Expression of peroxisome- proliferator activated receptor-gamma (PPARγ) and the PPARγ co-activator, PGC-1, in human breast cancer correlates with clinical outcomes. Int J Cancer 2003; 106: 752-7.
23. Parr C, Jiang WG. Quantitative analysis of lymphangiogenesis in human colon cancer. Int J Oncol 2003; 23: 533-9.
24. Davies G, Mason MD, Martin TA et al. The HGF/SF antagonist NK4 reverses fibroblast-and HGF-induced prostate tumor growth and angiogenesis in vivo. Int J Cancer 2003; 106: 348-54.
25. Nakamura Y, Yasuoka H, Tsujimoto M et al. Prognostic significance of vascular endothelial growth factor d in breast carcinoma with long-term follow-up. Clin Cancer Res 2003; 9: 716-21.
26. Feldman AL, Libutti SK. Progress in antiangiogenic gene therapy of cancer. Cancer 2000; 89: 1181-94.
27. Colombatti A, Bonaldo P. The superfamily of proteins with von Willebrand factor type A-like domains: one theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms. Blood 1991; 77: 2305-15.
28. Lee JO, Rieu P, Arnaout MA et al. Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell 1995; 80: 631-8.
29. Dickeson SK, Santoro SA. Ligand recognition by the I domain-containing integrins. Cell Mol Life Sci 1998; 54: 556-66.
30. Van der Vieren M, Crowe DT, Hoekstra D et al. The leukocyte integrin alpha D beta 2 binds VCAM-1: evidence for a binding interface between I domain and VCAM-1. J Immunol 1999; 163: 1984-90.
31. Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002; 2: 91-100.